We are delighted to announce the incorporation of ImmunoServ Ltd., a specialist contract research organisation in the immunology sector.

Read More

To stay updated on our latest news, please sign up to our newsletter.

Call or Email

Social Media

Cardiff University Alumni Announce UK-India Strategic Partnership for Immunity Testing

1st March 2023 on St David’s Day, ImmunoServ from Cardiff, Wales, UK signed a Strategic Partnership with ImmunitasBio of Bangalore, India to formalise its support for each other in their shared purpose in providing expert immunology products and services across the world.

Read More

ImmunoServ wins Judges Award at MediWales Innovation Awards

On Thursday 8th December MediWales held their seventeenth annual MediWales Innovation Awards in Cardiff. It was a fabulous evening celebrating collaboration and innovation across the Welsh life science and health and social care sectors. ImmunoServ were thrilled to win the prestigious Industry Judges Award.

Read More

COVID-19 Immuno-T™ T cell test grabs the headlines

Last month ImmunoServ’s latest research in collaboration with Cardiff University was published in the prestigious Nature Communications journal. The research is the culmination of many years research, devotion and hard work. We are especially grateful to all the volunteers who contributed to this work, as well as those who funded the work including UKRI, InnovateUK, and the National Core Studies.

Read More

Immuno-T COVID T Cell Test Now Available to Buy

At ImmunoServ we are on a mission to bring T cell testing to the masses. The World’s first At-Home COVID-19 T cell test is now available to anyone in the United Kingdom. People who wish to test their own T cell immune response to COVID-19 using Immuno-TTM, can visit our Immuno-T website.

Read More

UKCA / IVD mark achieved for Immuno-T At Home Blood Collection Kit

ImmunoServ is proud to announce that it has obtained the UKCA (UK Conformity Assessed) mark for its Immuno-T At Home Blood Collection Kit.

Read More

Recruitment for At Home Immuno-T Validation Study Complete

In January 2022 ImmunoServ launched its trial of the Worlds first At-Home combined COVID-19 T cell and antibody test. Participants from across the UK were invited to sign up to the validation study. Within 10 weeks more than 300 participants have been recruited.

Read More

ImmunoServ Appoints New CEO

ImmunoServ is pleased to announce the appointment of Dr James Hindley as our new Chief Executive Officer. James brings a wealth of immunology and entrepreneurial experience in guiding biotech ventures; his proven leadership in the field is an excellent fit for ImmunoServ’s mission to provide expert immunology services to the world.

Read More

Double Certification: ISO 9001 and Cyber Essentials

ImmunoServ is delighted to announce that the company’s commitment to Quality Assurance and Cyber Security has been independently verified.

Read More

Omicron T cell test under development

Following the WHOs announcement about the new SARS-CoV-2 Omicron variant of concern (VoC) on 26 November 2021, the team here at ImmunoServ have started working on a T cell immune response test for this variant. This rapid development demonstrates the flexibility of our T cell testing platform and the dedication of our company to help in the ongoing fight against COVID-19.

Read More

Single blood test to measure T-cell and antibody response to SARS-CoV-2

ImmunoServ have been featured by Cardiff University for our work on a test to measure both the T-cell and antibody response to SARS-CoV-2 in a single blood sample.

Read More

If you’re keen to work with us in achieving our vision please get in touch.